<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3C2AEA7-E80C-4871-BA29-B4842960D7C3"><gtr:id>F3C2AEA7-E80C-4871-BA29-B4842960D7C3</gtr:id><gtr:name>Aptamer Solutions</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:department>Biology</gtr:department><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3C2AEA7-E80C-4871-BA29-B4842960D7C3"><gtr:id>F3C2AEA7-E80C-4871-BA29-B4842960D7C3</gtr:id><gtr:name>Aptamer Solutions</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/18EBE62B-3066-4374-9736-781A6D6E3AA0"><gtr:id>18EBE62B-3066-4374-9736-781A6D6E3AA0</gtr:id><gtr:firstName>William</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Brackenbury</gtr:surname><gtr:orcidId>0000-0001-6882-3351</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000508"><gtr:id>AA5EA20B-EEB3-48FB-8135-73951D4FC3AD</gtr:id><gtr:title>Regulation of cancer cell migration by voltage-gated sodium channels</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1000508</gtr:grantReference><gtr:abstractText>The goal of this research proposal is to characterise a potentially new target in metastatic breast cancer. Metastasis is the process by which cancer cells spread from the primary tumour site to secondary sites. Metastasis is of major clinical importance, since it is the main cause of breast cancer mortality. The target of study is the voltage-gated sodium channel (VGSC). VGSCs are found on cells in the nervous system and muscle. Drugs that target VGSCs are used to treat diseases such as epilepsy, abnormal heartbeat and pain. VGSCs regulate the migration of neurones in the developing nervous system. VGSCs also occur in metastatic breast cancer cells and regulate cell behaviours associated with metastasis, including adhesion and migration. The research project, to be carried out at the University of York, will study VGSCs in human breast cancer cells, mice and biopsy samples. We will test the hypothesis that VGSCs control metastasis in breast cancer cells by a mechanism similar to that in migrating neurones. Based on this work, it is possible that VGSCs may be a useful new diagnostic target in breast cancer. In addition, VGSC-targeting drugs may be effective for therapeutic intervention in breast cancer, to reduce and/or slow metastasis.</gtr:abstractText><gtr:technicalSummary>The long-term goal of this research is to elucidate the functional role of voltage-gated Na+ channels (VGSCs) in breast cancer (BCa) metastasis. VGSCs exist as membrane complexes containing a pore-forming subunit with one or two subunits. Through the 1 subunit, which is an immunoglobulin (Ig) superfamily cell adhesion molecule, VGSCs regulate migration of neurones in the developing CNS in vivo. Recent work, largely restricted to in vitro models, has shown that VGSC and 1 subunits are expressed in metastatic BCa cells, and regulate cell behaviours associated with metastasis, including adhesion, migration and invasion. This proposal aims to test the hypothesis that VGSCs control cellular migration and invasion in metastatic BCa, by a mechanism that recapitulates neuronal signalling. In addition to using in vitro cell lines, I will develop an in vivo approach, using an established animal model and human biopsy material to characterise the expression and activity of VGSCs in metastatic BCa. I propose three specific aims. In Aim 1, I will investigate the mechanism of 1-mediated signalling in regulating the adhesion and migration of BCa cells. Specifically, I will test whether mechanism(s) underlying 1-mediated adhesion and migration in BCa cells may be analogous to those operating in neurones, using a combination of functional in vitro adhesion, migration and invasion assays, Western blotting and confocal immunocytochemistry. In Aim 2, I will investigate whether VGSC expression affects tumour formation and/or metastasis in nude mice in vivo. I will then test whether the VGSC-inhibiting drug phenytoin affects the tumour formation and/or metastasis. In Aim 3, I will determine whether VGSC expression and activity correlates with metastatic potential in human BCa tumour biopsies, using a combination of tissue microarrays, immunohistochemistry, realtime PCR, functional assays, Western blotting, confocal microscopy and patch clamp recording. The study will characterise VGSCs as new potential diagnostic and therapeutic targets in BCa, which is the most commonly diagnosed cancer in women, and the second-leading cause of cancer-related deaths. In particular, the study focuses on the process of metastasis, which is of major clinical importance, since it is the main cause of BCa mortality. Given that VGSCs are well established as clinical targets in the treatment of other diseases, such as epilepsy and pain, based on this work, it is possible that VGSC-modulating drugs already in use may also be effective in BCa therapy.</gtr:technicalSummary><gtr:fund><gtr:end>2016-01-16</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-01-17</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>766981</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aptamer Solutions</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Aptamer Solutions Ltd</gtr:description><gtr:id>4A229CAD-856D-4D89-BA9E-A04B476976E6</gtr:id><gtr:impact>MRC Industrial CASE Training Grant MR/K016296/1</gtr:impact><gtr:outcomeId>Bu8Cog1jEik-1</gtr:outcomeId><gtr:partnerContribution>Supported application and will host PhD student to develop RNA aptamers.</gtr:partnerContribution><gtr:piContribution>Applied for and awarded (starting October 2013) an MRC Industrial CASE PhD Studentship to develop RNA aptamers to target sodium channel beta-1 subunit.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public Talk at YorNight</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A3F46264-5E8B-4923-BF10-FDF65D1CE56A</gtr:id><gtr:impact>Short talk on our research to an audience of ~50 members of the general public during YorNight, part of the European Researchers' Night, at York Medical Society.</gtr:impact><gtr:outcomeId>56b07d90525fa8.83482742</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://yornight.com/2015/activities/medical-society/antiepileptic-drugs-to-treat-cancer/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with medicalresearch.com January 2015</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4847E8AC-5333-4AD0-98B7-7D51876135F4</gtr:id><gtr:impact>Interview with medicalresearch.com on our publication: Nelson M, Yang M, Dowle AA, Thomas JR and Brackenbury WJ. The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis. Mol. Cancer 14, 2015, 13.</gtr:impact><gtr:outcomeId>56b092dd1b51e4.18474630</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://medicalresearch.com/cancer-_-oncology/breast-cancer/study-attacks-breast-cancer-metastases-with-seizure-medicationstases-with-seizure-medication/11118/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosting visiting PhD student</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>09497C12-955E-4030-A78B-551714427B9F</gtr:id><gtr:impact>A PhD student from Tufts University visited the laboratory in order to learn electrophysiology techniques in cancer cells.</gtr:impact><gtr:outcomeId>56b0941230aee3.17244881</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8E9EB796-A8D8-47A7-81AC-BE08E99416AD</gtr:id><gtr:impact>Press release on publication of paper: Nelson M, Millican-Slater R, Forrest LC and Brackenbury WJ. The sodium channel ?1 subunit mediates outgrowth of neurite-like processes on breast cancer cells and promotes tumour growth and metastasis. Int. J. Cancer, 135, 2014, 2338-2351.</gtr:impact><gtr:outcomeId>56b090beea41f0.02837845</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.york.ac.uk/biology/news-events/news/breastcancer/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Leeds 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3CFD7BA9-ADED-415D-8A30-2344FA289000</gtr:id><gtr:impact>&amp;quot;Sodium channels, brain development and breast cancer.&amp;quot; School of Molecular and Cellular Biology, University of Leeds, November 2013.

NA</gtr:impact><gtr:outcomeId>Z3Lwit2699b</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at University of Tours</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>15396A46-F18F-4044-92D2-B87F989B3EDD</gtr:id><gtr:impact>Invited seminar on &amp;quot;Targeting breast cancer with phenytoin.&amp;quot; 2015, Universit&amp;eacute; Fran&amp;ccedil;ois-Rabelais de Tours, France.</gtr:impact><gtr:outcomeId>56b09392582503.17925928</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>York Soc Engineers 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F7049575-1C28-4871-93BD-62F9E7437688</gtr:id><gtr:impact>30 members of the York Society of Engineers attended shorts talks on cancer research by PhD students from our department (including one of my students), then guided tours of the research labs, followed by a buffet dinner with the PIs.

Charitable income generation for York Against Cancer.</gtr:impact><gtr:outcomeId>K5TYCBCMQEZ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Twitter feed</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>528FAF08-18E6-4CD5-9BD4-27AC4BE96406</gtr:id><gtr:impact>Open Twitter feed updating on research progress in laboratory and wider field.</gtr:impact><gtr:outcomeId>56b091b26b9d83.91154313</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://twitter.com/WJBrackenbury</gtr:url><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release on publication</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>15488588-40D5-40EA-A97D-217EA5FB55FC</gtr:id><gtr:impact>Press release highlighting publication of: Nelson M, Yang M, Dowle AA, Thomas JR and Brackenbury WJ. The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis. Mol. Cancer 14, 2015, 13.</gtr:impact><gtr:outcomeId>56b07e59387633.15671245</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.york.ac.uk/biology/news-events/news/potentialanti-canceruseforanti-epilepsydrug/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with medicalresearch.com 2015</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0F60856B-E0FD-4FB6-B05A-21DCE7FD44C4</gtr:id><gtr:impact>Interview with medicalresearch.com on our research into using antiepileptic drugs to treat cancer.</gtr:impact><gtr:outcomeId>56b0925bf33010.35624377</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://medicalresearch.com/cancer-_-oncology/breast-cancer/seizure-medication-may-fight-breast-cancer-metastases/18465/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nuffield-funded A level student work placement</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1F40DD58-CD0C-4AF2-936B-F99058922AF4</gtr:id><gtr:impact>Nuffield Foundation-funded A level student visited the lab to participate in research techniques for 3 weeks.

Student was from a local school in York.</gtr:impact><gtr:outcomeId>Lf69kHsnwof</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Manchester 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9F77B8F1-A1A6-49E8-AC7B-160EB6F14561</gtr:id><gtr:impact>Invited research seminar at the University of Manchester.

NA</gtr:impact><gtr:outcomeId>544813aa022b12.47835201</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with BBC Radio York</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>33CEEF65-385B-4343-8827-9F09A9699063</gtr:id><gtr:impact>Interview with BBC Radio York to discuss our research on use of antiepileptic drugs to treat metastasis.</gtr:impact><gtr:outcomeId>56b07eadb581c0.53479322</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Leeds talk 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BB9F1A8E-0D1B-4908-9B11-4B877B162739</gtr:id><gtr:impact>&amp;quot;Voltage-gated Na+ channels: potential targets for cancer therapy?&amp;quot; Faculty of Biological Sciences, University of Leeds, 2012.

NA</gtr:impact><gtr:outcomeId>aCRmmVWHpWP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A level student work placement</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2FCEF27C-5464-4D08-A976-B0E479FCF230</gtr:id><gtr:impact>A level students visit my laboratory for two weeks during the summer vacation in order to gain experience of working in a cell biology lab.

The student appeared keen to apply for a bioscience degree following this experience.</gtr:impact><gtr:outcomeId>sNdZvbyk7Qw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>9965</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Physiological Society</gtr:fundingOrg><gtr:id>B9169F8C-DF9B-4A8E-A0C4-BC35C752A955</gtr:id><gtr:outcomeId>5899961bbf7e14.37062235</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>91916</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship Grant</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Breast Cancer Campaign (BCC)</gtr:fundingOrg><gtr:id>6CB9BC30-B38F-43C3-A910-A4C6569D7059</gtr:id><gtr:outcomeId>56b07c342b97b5.71396897</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>107400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Industrial CASE PhD Studentship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K016296/1</gtr:fundingRef><gtr:id>E5362F18-BA13-4359-900F-18C91008C5FD</gtr:id><gtr:outcomeId>LKdEdi1tiht</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58947</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome ISSF</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>University of York</gtr:fundingOrg><gtr:id>5FDD60BE-3205-46FE-BF2C-C0D594C7F937</gtr:id><gtr:outcomeId>56b07be1c5ffa6.28061584</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>36046</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome ISSF</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>University of York</gtr:fundingOrg><gtr:id>AE49D43C-0242-4BA5-A8C8-AD27EBBCC41D</gtr:id><gtr:outcomeId>543d73ce9d4d81.25778253</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8333799</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Grant</gtr:description><gtr:end>2020-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M008991/1</gtr:fundingRef><gtr:id>4BF07DAF-FE21-44A7-B242-2944AF232009</gtr:id><gtr:outcomeId>544811807d77d3.88450159</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cancer Research UK Big Think</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8C3142CC-F19B-4EB2-AA29-B308E64AFCF7</gtr:id><gtr:outcomeId>56b095fdcebfc0.44761265</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have develop[ed, optimised and applied in vivo whole cell patch clamp recording to intact mammary tumour tissue slices for the first time.</gtr:description><gtr:id>F1AD93EE-AE5B-4085-A122-909A5A2D4870</gtr:id><gtr:impact>Publication: Nelson M, Yang M, Millican-Slater R and Brackenbury WJ. Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo. Oncotarget, 6, 2015, 32914-32929.</gtr:impact><gtr:outcomeId>56b096db895573.41504375</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Breast cancer tissue slice recording</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Fixed frozen tissue sections from various organs from mammary tumour-bearing mice treated with/without phenytoin.</gtr:description><gtr:id>ACFE1F3A-75D3-43FC-8AB6-D6C94251E6B9</gtr:id><gtr:impact>We have shared this tissue resource via the SEARCHBreast initiative.</gtr:impact><gtr:outcomeId>56b0975f55f1c1.67589785</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Fixed frozen tissue sections</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>https://searchbreast.org</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>04E43C7B-7B5A-4BF8-8BBC-0CCA1E629A4C</gtr:id><gtr:title>Sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care database.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c945ff0223ee15c8c72b32f599fe87eb"><gtr:id>c945ff0223ee15c8c72b32f599fe87eb</gtr:id><gtr:otherNames>Fairhurst C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>585d3af5592e29.68565844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6919D393-3E7B-4F95-9434-2B659F10007B</gtr:id><gtr:title>Exposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care database.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c945ff0223ee15c8c72b32f599fe87eb"><gtr:id>c945ff0223ee15c8c72b32f599fe87eb</gtr:id><gtr:otherNames>Fairhurst C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>doi_55f9859856b09def</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EF6B0FC-1BD2-427E-AFEF-BE876217D5D6</gtr:id><gtr:title>Voltage-gated sodium channels and metastatic disease.</gtr:title><gtr:parentPublicationTitle>Channels (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/491a4a051028639fe5a363c4f1372e9a"><gtr:id>491a4a051028639fe5a363c4f1372e9a</gtr:id><gtr:otherNames>Brackenbury WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-6950</gtr:issn><gtr:outcomeId>pm_12597_27_22992466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>086A5F19-2BFA-4C84-B6AF-9134C7AD304D</gtr:id><gtr:title>Na Channel ? Subunits: Overachievers of the Ion Channel Family.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/491a4a051028639fe5a363c4f1372e9a"><gtr:id>491a4a051028639fe5a363c4f1372e9a</gtr:id><gtr:otherNames>Brackenbury WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>pm_12597_27_22007171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1952DCD9-3880-48A5-96DD-EA8170A1F690</gtr:id><gtr:title>Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic Review.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6749b7fb8b90ae10766864fe00a3159f"><gtr:id>6749b7fb8b90ae10766864fe00a3159f</gtr:id><gtr:otherNames>Martin F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>56b07a47b79c18.17330233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90A3B71F-0937-4464-A1C9-8EBD851CDB27</gtr:id><gtr:title>Membrane potential and cancer progression.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/568b1bdfe155aa165382b901542f1efb"><gtr:id>568b1bdfe155aa165382b901542f1efb</gtr:id><gtr:otherNames>Yang M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn><gtr:outcomeId>pm_12597_27_23882223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07FA6951-689E-4BFC-92CD-2005B2297134</gtr:id><gtr:title>The sodium channel ?1 subunit mediates outgrowth of neurite-like processes on breast cancer cells and promotes tumour growth and metastasis.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/782866de2b1b9f67d69dd942fc74dba4"><gtr:id>782866de2b1b9f67d69dd942fc74dba4</gtr:id><gtr:otherNames>Nelson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>54480eafbd26a9.40509368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D2E7443-E7FF-469E-9A05-DA10ADDFDB50</gtr:id><gtr:title>Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based study.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c945ff0223ee15c8c72b32f599fe87eb"><gtr:id>c945ff0223ee15c8c72b32f599fe87eb</gtr:id><gtr:otherNames>Fairhurst C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56b0793e894fd1.85088013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>699D5011-5345-4C23-9BD1-AB57DB6C9195</gtr:id><gtr:title>Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dc15ec5a3bd07435ff06b9392b11323"><gtr:id>6dc15ec5a3bd07435ff06b9392b11323</gtr:id><gtr:otherNames>Fraser SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>pm_540e172e172939b96</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>030731B7-73D2-40D6-8EF0-F6048B8AB83C</gtr:id><gtr:title>Abnormal neuronal patterning occurs during early postnatal brain development of Scn1b-null mice and precedes hyperexcitability.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/491a4a051028639fe5a363c4f1372e9a"><gtr:id>491a4a051028639fe5a363c4f1372e9a</gtr:id><gtr:otherNames>Brackenbury WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56b0793f271783.93228584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AE7BC1E-85C4-47FC-BDF3-1D4670B73562</gtr:id><gtr:title>Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells.</gtr:title><gtr:parentPublicationTitle>International journal of oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10dd00cdc03141f77b8fbab5e83bf7a0"><gtr:id>10dd00cdc03141f77b8fbab5e83bf7a0</gtr:id><gtr:otherNames>Mohammed FH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1019-6439</gtr:issn><gtr:outcomeId>56b0793e5f3015.35255882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6901D453-4E35-4ECE-BF95-392C07707A3A</gtr:id><gtr:title>Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.</gtr:title><gtr:parentPublicationTitle>Breast cancer research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/568b1bdfe155aa165382b901542f1efb"><gtr:id>568b1bdfe155aa165382b901542f1efb</gtr:id><gtr:otherNames>Yang M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0167-6806</gtr:issn><gtr:outcomeId>pm_12597_27_22678159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ED39514-098E-40DB-AC72-24A5A01F450A</gtr:id><gtr:title>Na+ channel Scn1b gene regulates dorsal root ganglion nociceptor excitability in vivo.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7d7b50c906d336cef6fda6bc2a113e1"><gtr:id>a7d7b50c906d336cef6fda6bc2a113e1</gtr:id><gtr:otherNames>Lopez-Santiago LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12597_27_21555511</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4FCF3BB-AE78-4B5A-AD9A-A5342CCE9509</gtr:id><gtr:title>Inhibition of N1-Src kinase by a specific SH3 peptide ligand reveals a role for N1-Src in neurite elongation by L1-CAM.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/989dbb9999ff0843556d5d54b13bcefd"><gtr:id>989dbb9999ff0843556d5d54b13bcefd</gtr:id><gtr:otherNames>Keenan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a83f4bf705ce3.27053411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>441B2F41-D7EA-4030-8A22-215AFDA30F9C</gtr:id><gtr:title>Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/782866de2b1b9f67d69dd942fc74dba4"><gtr:id>782866de2b1b9f67d69dd942fc74dba4</gtr:id><gtr:otherNames>Nelson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>56b0793ebeb9e9.43090086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C76D1BE-94DE-4FB3-83B1-3C00DA6C524F</gtr:id><gtr:title>Ion Channels in Health and Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06d1ea52a4c72222dddd2a08a9e6f844"><gtr:id>06d1ea52a4c72222dddd2a08a9e6f844</gtr:id><gtr:otherNames>Brackenbury W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:isbn>9780128020029</gtr:isbn><gtr:outcomeId>5899956f977778.00385198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82C64C3B-2E22-437D-AB80-C13D92E8EB1B</gtr:id><gtr:title>The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis.</gtr:title><gtr:parentPublicationTitle>Molecular cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/782866de2b1b9f67d69dd942fc74dba4"><gtr:id>782866de2b1b9f67d69dd942fc74dba4</gtr:id><gtr:otherNames>Nelson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1476-4598</gtr:issn><gtr:outcomeId>doi_55f9859856ba1581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BB5EB41-7E9B-4819-B022-AD1ED89B3FFC</gtr:id><gtr:title>IK channel activation increases tumor growth and induces differential behavioral responses in two breast epithelial cell lines.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f531ea1d6ae97b1bd68e9bb5a3a89385"><gtr:id>f531ea1d6ae97b1bd68e9bb5a3a89385</gtr:id><gtr:otherNames>Thurber AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>5a5f60fe4f3756.18300568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB41111E-4939-46C7-B26C-8A58BB9E4553</gtr:id><gtr:title>Voltage-gated Na+ channel ?1B: a secreted cell adhesion molecule involved in human epilepsy.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c26d8a9a95458eb6eaa00d647545b36"><gtr:id>9c26d8a9a95458eb6eaa00d647545b36</gtr:id><gtr:otherNames>Patino GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_12597_27_21994374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32CB480D-4AA5-44CC-8F1E-47D452D39BC0</gtr:id><gtr:title>Dual roles of voltage-gated sodium channels in development and cancer.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56200c89dc900bbd19628ed151971899"><gtr:id>56200c89dc900bbd19628ed151971899</gtr:id><gtr:otherNames>Patel F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>56b0793ee804e6.01389067</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000508</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>